Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Antimicrob Agents Chemother ; 60(5): 3202-6, 2016 05.
Artigo em Inglês | MEDLINE | ID: mdl-26953211

RESUMO

We expressed the wild-type rplC and mutated rplC (Cys154Arg) genes, respectively, in Mycobacterium tuberculosis H37Ra and H37Rv in an attempt to delineate the role of rplC (Cys154Arg) regarding oxazolidinone resistance. An increase of the MICs of linezolid (LZD) and sutezolid (PNU-100480, PNU) against the recombinant mycobacteria with overexpressed rplC mutation (Cys154Arg) was found, suggesting the rplC gene is a determinant of bacillary susceptibilities to LZD and PNU.


Assuntos
Antituberculosos/farmacologia , Mycobacterium tuberculosis/metabolismo , Oxazolidinonas/farmacologia , Proteínas Ribossômicas/metabolismo , Linezolida/farmacologia , Testes de Sensibilidade Microbiana , Mutação , Mycobacterium tuberculosis/efeitos dos fármacos , Mycobacterium tuberculosis/genética , Proteína Ribossômica L3 , Proteínas Ribossômicas/genética
2.
PLoS One ; 10(3): e0119341, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25760622

RESUMO

In our previous study, we demonstrated that the use of the autoluminescent Mycobacterium tuberculosis as a reporter strain had the potential to drastically reduce the time, effort, animals and costs consumed in evaluation of the activities of drugs and vaccines in live mice. However, the strains were relatively unstable and lost reporter with time without selection. The kanamycin selection marker used wasn't the best choice as it provides resistance to amino glycosides which are an important class of second line drugs used in tuberculosis treatment. In addition, the marker could limit utility of the strains for screening of new potential drugs or evaluating drug combinations for tuberculosis treatment. Limited selection marker genes for mycobacterial genetic manipulation is a major drawback for such a marker-containing strain in many research fields. Therefore, selectable marker-free, more stable autoluminescent mycobacteria are highly needed. After trying several strategies, we created such mycobacterial strains successfully by using an integrative vector and removing both the resistance maker and integrase genes by Xer site-specific recombination in one step. The corresponding plasmid vectors developed in this study could be very convenient in constructing other selectable marker-free, more stable reporter mycobacteria with diverse applications.


Assuntos
Engenharia Genética/métodos , Proteínas Luminescentes/metabolismo , Mycobacterium tuberculosis/genética , Animais , Proteínas de Bactérias/genética , Descoberta de Drogas/economia , Vetores Genéticos/genética , Vetores Genéticos/metabolismo , Integrases/genética , Resistência a Canamicina , Proteínas Luminescentes/genética , Camundongos , Mycobacterium tuberculosis/enzimologia , Mycobacterium tuberculosis/metabolismo , Plasmídeos/genética , Plasmídeos/metabolismo , Transformação Bacteriana
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa